Chemotherapy Competency Week 1
Weekly review of knowledge and skills essential for safe administration of chemotherapy. Complete quiz weekly and your name will be entered in drawing for 10 tickets equaling 1 hour of PTO. Please email me your questions, answers, and supportive documentaton for next weeks quiz!
- 1.A common Benzodiazepine used to treat nausea and vomiting in chemotherapy is
- A.
Aloxi (palonosetron)
- B.
Emend (aprepitant)
- C.
Ativan (lorazepam)
- D.
Compazine (prochlorperazine)
- 2.Your patient asks, "Why exactly does chemotherapy make you lose your hair?" How will you answer?
- A.
"I'm not sure. Your should ask your provider during your next visit."
- B.
"Cells responsible for hair growth are rapidly dividing and chemotherapy kills rapidly dividing cells."
- C.
"Wearing an ice cap on your head will prevent hair loss."
- D.
"Don't worry. It happens to everyone. It will grow back>"
- 3.You are making your rounds in the treatment room when you notice an IV rate that is inconsistent with the drug & volume being infused. Your next action should be
- A.
Ignore it. It is not your patient.
- B.
Pause the infusion. Find the patients nurse and clarify rate desired.
- C.
Leave as is. Find the patients nurse and clarify rate desired.
- D.
Change the rate and say nothing.
- 4.What drug is given with fluorouracil (Adrucil/5FU) to potentiate its effects and with methotrexate to protect normal cells?
- A.
Leucovorin
- B.
Vitamin B12
- C.
Folate
- D.
Camptosar
- 5.What teaching is necessary in the patient who is expected to experience mucositis?
- A.
Oral assessment
- B.
Mouth care
- C.
Nutritional support
- D.
All of the above
- 6.When does the nadir most commonly occur?
- A.
3-5 days post chemotherapy
- B.
10-14 days post chemotherapy
- C.
7-10 days post chemotherapy
- D.
14-18 days post chemotherapy
- 7.What is often the first symptom of oral mucositis?
- A.
Pain and ulceration in the mouth and throat
- B.
Mouth bleeding
- C.
Visible ulcerations in the mouth
- D.
Burning sensation in the mouth
- 8.Advanced age causes an increased risk of neutropenia.
- A.
True
- B.
False
- 9.Mrs Smith will be receiving T/C for her breast cancer. Taxotere iIV s ordered at 75 mg per m2 and Cytoxan IV is ordered at 600 mg per m2. Mrs. Smith is 5'7" and weighs 146 pounds. Her expected dose of each of these drugs would be
- A.
Taxotere 133 mg, Cytoxan 700 mg.
- B.
Taxotere 125 mg, Cytoxan 1000mg.
- C.
Taxotere 133 mg., Cytoxan 1062 mg.
- D.
Taxotere 120 mg., Cytoxan 1062 mg.
- 10.What non-hematopoietic secondary malignancy is associated with cyclophosphamide (Cytoxan) administration?
- A.
Bladder Cancer
- B.
Uterine cancer
- C.
Lung cancer
- D.
Leukemia
Back to top